Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 434

Related Citations for PubMed (Select 16857805)

1.

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.

Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA, Cui X, Cummings TJ, Bigner DD, Gilboa E, Sampson JH.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4294-305.

2.

Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.

Fecci PE, Ochiai H, Mitchell DA, Grossi PM, Sweeney AE, Archer GE, Cummings T, Allison JP, Bigner DD, Sampson JH.

Clin Cancer Res. 2007 Apr 1;13(7):2158-67.

3.

[Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].

Zhang P, Zhang LN, Zhu FL, Wang Q, Wang XY, Li HY, Liu CM, Gao F, Liu CH.

Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):342-5. Chinese.

PMID:
17892128
4.

Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.

Ahn JS, Krishnadas DK, Agrawal B.

Int Immunol. 2007 Mar;19(3):227-37. Epub 2007 Feb 7.

5.

Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.

Forward NA, Furlong SJ, Yang Y, Lin TJ, Hoskin DW.

J Leukoc Biol. 2010 Jan;87(1):117-25. doi: 10.1189/jlb.0908559. Epub 2009 Oct 20.

6.

Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.

Ohmura Y, Yoshikawa K, Saga S, Ueda R, Kazaoka Y, Yamada S.

Oncol Rep. 2008 May;19(5):1265-70.

PMID:
18425386
7.

Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.

Heier I, Hofgaard PO, Brandtzaeg P, Jahnsen FL, Karlsson M.

Clin Exp Immunol. 2008 May;152(2):381-7. doi: 10.1111/j.1365-2249.2008.03642.x. Epub 2008 Mar 12.

8.

Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.

Forward NA, Furlong SJ, Yang Y, Lin TJ, Hoskin DW.

J Immunol. 2009 Sep 1;183(5):3014-22. doi: 10.4049/jimmunol.0802509. Epub 2009 Aug 10.

9.

Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.

De Somer L, Fevery S, Bullens DM, Rutgeerts O, Lenaerts C, Mathieu C, Boon L, Kasran A, Waer M, Billiau AD.

Immunol Lett. 2010 Sep 6;133(1):49-53. doi: 10.1016/j.imlet.2010.06.005. Epub 2010 Jun 18.

PMID:
20600326
10.

Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.

Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N.

Cell Res. 2007 Jul;17(7):627-37.

11.

Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.

Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A.

Transplantation. 2007 Jul 15;84(1):31-9.

PMID:
17627234
12.
13.

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T, Sakaguchi S.

J Exp Med. 2005 Oct 3;202(7):885-91. Epub 2005 Sep 26. Erratum in: J Exp Med. 2012 Feb 13;209(2):423.

14.

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P, Sutmuller RP, Adema GJ.

Int J Cancer. 2007 Jul 1;121(1):95-105.

PMID:
17315190
15.
16.
17.

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.

Grauer OM, Sutmuller RP, van Maren W, Jacobs JF, Bennink E, Toonen LW, Nierkens S, Adema GJ.

Int J Cancer. 2008 Apr 15;122(8):1794-802.

PMID:
18076066
18.

Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.

Xia G, He J, Leventhal JR.

Am J Transplant. 2008 Feb;8(2):298-306. doi: 10.1111/j.1600-6143.2007.02088.x. Epub 2008 Jan 7.

19.

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Tadmor T, Zhang Y, Cho HM, Podack ER, Rosenblatt JD.

Cancer Immunol Immunother. 2011 May;60(5):609-19. doi: 10.1007/s00262-011-0972-z. Epub 2011 Jan 21.

PMID:
21253724
20.

CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.

Razmara M, Hilliard B, Ziarani AK, Chen YH, Tykocinski ML.

Int Immunol. 2008 Apr;20(4):471-83. doi: 10.1093/intimm/dxn007. Epub 2008 Feb 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk